Company Filing History:
Years Active: 2025
Title: Innovations by Regis Vilchez in Hepatic Encephalopathy Treatment.
Introduction
Regis Vilchez is an accomplished inventor based in Hazelwood, MO (US). He has made significant contributions to the field of medicine, particularly in the treatment of hepatic encephalopathy (HE). His innovative approaches aim to improve patient outcomes and enhance the understanding of this complex condition.
Latest Patents
Regis Vilchez holds a patent for "Methods of assessing hepatic encephalopathy." This patent outlines methods for treating or ameliorating HE, including assessing its severity in patients. The disclosure introduces a novel Hepatic Encephalopathy Staging Tool (HEST), which categorizes HE into different stages and provides guidance on effective treatments based on severity. Additionally, the patent features an Overt Hepatic Encephalopathy Screening Tool (O-HEST) to determine the occurrence of overt HE events and guide medical attention and treatment adjustments.
Career Highlights
Regis Vilchez has dedicated his career to advancing medical science through innovative solutions. His work at Amalive Limited has positioned him as a key player in the development of tools that enhance the assessment and treatment of hepatic encephalopathy. His commitment to improving patient care is evident in his research and patent contributions.
Collaborations
Regis collaborates with Stanley Bukofzer, working together to further their research and innovations in the medical field. Their partnership exemplifies the importance of teamwork in driving advancements in healthcare.
Conclusion
Regis Vilchez's contributions to the treatment of hepatic encephalopathy through his innovative patents and collaborative efforts highlight his dedication to improving patient care. His work continues to pave the way for advancements in medical treatment and assessment.